CE marking is not optional for stainless steel medical devices entering the European market. Under the EU Medical Device Regulation (MDR) 2017/745, which replaced the older Medical Device Directive (MDD) in May 2021, manufacturers must demonstrate comprehensive compliance with safety and performance requirements before products can be legally sold in the European Economic Area (EEA) [1].
For Southeast Asian manufacturers looking to sell on Alibaba.com and reach European buyers, understanding CE certification is not just about regulatory compliance—it's about building trust and accessing a market valued at billions of dollars. The surgical stainless steel market alone is projected to grow from USD 6.32 billion in 2024 to USD 8.78 billion by 2033, representing significant opportunities for compliant suppliers [5].
The MDR introduced several critical changes that directly impact stainless steel medical device manufacturers. Most notably, the regulation now requires stricter biocompatibility testing and places explicit limits on cobalt content in stainless steel alloys used for medical applications. Alloys with cobalt content exceeding 0.10 wt% require warning labels, and many manufacturers are transitioning to low-cobalt stainless steel alternatives to avoid this requirement entirely [1].
EU MDR 2017/745 requires comprehensive documentation for medical device manufacturers. CE marking indicates the manufacturer has assessed the device and it meets General Safety and Performance Requirements. Technical documentation must demonstrate conformity, and Notified Body involvement is mandatory for Class II and Class III devices [2].

